IgY Antibodies as Biotherapeutics in Biomedicine

Diana León-Núñez, María Fernanda Vizcaíno-López, Magdalena Escorcia, Dolores Correa, Elizabeth Pérez-Hernández, Fernando Gómez-Chávez

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

8 Citas (Scopus)

Resumen

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases. Antibodies are relatively easy to obtain from any species with an adaptive immune system, but birds are animals characterized by relatively easy care and maintenance. In addition, the antibodies they produce can be purified from the egg yolk, allowing a system for obtaining them without performing invasive practices, which favors the three “rs” of animal care in experimentation, i.e., replacing, reducing, and refining. In this work, we carry out a brief descriptive review of the most outstanding characteristics of so-called “IgY technology” and the use of IgY antibodies from birds for basic experimentation, diagnosis, and treatment of human beings and animals.

Idioma originalInglés
Número de artículo62
PublicaciónAntibodies
Volumen11
N.º4
DOI
EstadoPublicada - dic. 2022

Huella

Profundice en los temas de investigación de 'IgY Antibodies as Biotherapeutics in Biomedicine'. En conjunto forman una huella única.

Citar esto